- STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&AProving out a "synthetic lethality" approach can help treat cancer will take a lot more work. It also might trigger some creative deal-making.STAT · 1mo ago↗ source
- HHS responds coolly to paper on alcohol riskSoda and liver cancer, scientists conflicted on a new NIH proposal, and more health news from Morning RoundsSTAT · 1mo ago↗ source
- Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850In 2025, Elizabeth Selvin and her colleagues published in Nature Medicine for free. In 2026, it cost them $12,850, she writes.STAT · 1mo ago↗ source